These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 16458777)

  • 1. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
    Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?
    Hermanto U; Frija EK; Lii MJ; Chang EL; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1135-44. PubMed ID: 17208388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
    Shaffer R; Nichol AM; Vollans E; Fong M; Nakano S; Moiseenko V; Schmuland M; Ma R; McKenzie M; Otto K
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1177-84. PubMed ID: 19560880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
    Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
    Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
    Würschmidt F; Bünemann H; Heilmann HP
    Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
    Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.